B12, folate testing not routine screening: RCPA

complementary medicines spill out of bottle
Today, the Royal College of Pathologists of Australasia has announced a new position statement clarifying the use and interpretation of Vitamin B12 and Folate testing for diagnosing and monitoring deficiency. The RCPA’s position statement provides guidance to clinicians in the context of the recent changes to the relevant items in the Australian Medical Benefits Schedule.

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous PSA, PSNZ partner on postgrad education for Kiwi pharmacists
Next Overweight are most likely to drink sugary soft drink